
51 - 200 employees
Founded 2019
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 $210M Series B on 2021-06
Healthcare • Consulting • Manufacturing
Umoja Biopharma is a pioneering biopharmaceutical company focused on developing innovative in vivo CAR T cell therapies for cancer treatment. Their flagship technology, the VivoVec platform, enables the generation of CAR T cells directly within a patient's body, significantly streamlining the process compared to traditional ex vivo methods. Umoja Biopharma is dedicated to enhancing patient care by making cancer treatments more accessible and effective, backed by their own in-house manufacturing capabilities that ensure quality and reliability in their therapeutic production.
Selected: 🆕 Date Added.
🔥 14 hours ago
Senior regulatory leader advancing Umoja Biopharma’s in vivo CAR-T therapies. Developing global filing strategies and guiding regulatory interactions for transformative cancer treatments.
⛰️ Colorado, Washington – Remote
💵 $249.9k - $362.3k / year
💰 $210M Series B on 2021-06
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
👻 Ghost score 0%